Sigthor Sigmarsson

Sigthor Sigmarsson is an experienced board member and investment professional, currently serving as a Board Member at Meniga and Genís, and as Chairman of the Board at 3Z Pharmaceuticals and indó iceland. With a significant background in investment management, Sigthor is also Head of the Investment Committee for MF2 and MF3 Mezzanine Funds. Previous roles include Finance Director at Novator Partners LLP and Chairman of the Board for NOVA. Sigthor’s experience spans various sectors, particularly telecommunications and pharmaceuticals. Educational qualifications include a C.Sc in Electronic Engineering from Háskóli Íslands.